மிச்சிகன் இருதய கூட்டமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மிச்சிகன் இருதய கூட்டமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மிச்சிகன் இருதய கூட்டமைப்பு Today - Breaking & Trending Today

Physician-patient gender concordance may not matter in interventional practice


 E-Mail
While some studies suggest female patients treated by female physicians have better outcomes, there does not appear to be a relationship between operator and patient gender and outcome in patients undergoing coronary angioplasty or stenting. These are the results of a first-of-its-kind study by the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) and published in
Catheterizations and Cardiovascular Interventions.
The study looked at procedures performed by 385 male interventional cardiologists, and 18 female interventional cardiologists at 48 non-federal hospitals across the state of Michigan. Female interventional cardiologists continue to be markedly under-represented and only perform a small percentage of cases, with women accounting for only 4.5% of interventional cardiologists and performing only 3% of procedures. ....

United States , State Of Michigan , Prasanthi Yelavarthy , Michigan Medicine Frankel Cardiovascular Center , Michigan Society Of Thoracic , Blue Cross Shield , Michigan Cardiovascular Consortium , Michigan Society , Medicine Health , Death Dying , Mortality Longevity , Health Professionals , Internal Medicine , ஒன்றுபட்டது மாநிலங்களில் , நிலை ஆஃப் மிச்சிகன் , மிச்சிகன் மருந்து பிராங்கல் இருதய மையம் , மிச்சிகன் சமூகம் ஆஃப் தொராசி , நீலம் குறுக்கு கவசம் , மிச்சிகன் இருதய கூட்டமைப்பு , மிச்சிகன் சமூகம் , மருந்து ஆரோக்கியம் ,

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry


 
(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a bioabsorbable polymer, according to the results of a retrospective analysis.
Among more than 53,000 consecutive PCIs performed between 2015 and 2018 in Michigan, researchers found there was no difference in the risk of in-hospital mortality or stent thrombosis between patients who received the bioabsorbable-polymer everolimus-eluting stent (Synergy; Boston Scientific) and those treated with either the durable-polymer everolimus-eluting stent (Xience; Abbott Vascular) or the durable-polymer zotarolimus-eluting stent (Resolute; Medtronic).
Importantly, at 2 years, there was also no significant difference in the risk of death between the stent groups. ....

New York , United States , Ann Arbor , Ajay Kirtane , Nadia Sutton , Drug Administration Manufacturer , Presbyterian Hospital Columbia University Irving Medical Center , Boston Scientific , Md University Of Michigan Cardiovascular Center , Abbott Vascular , Michigan Cardiovascular Center , Drug Administration , User Facility Device Experience , Blue Cross Shield , Michigan Cardiovascular Consortium , Published February , Cardiovascular Interventions , Columbia University Irving Medical Center , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஆண்டு ஆர்பர் , அஜய கீர்த்தனே , நாடியா சுட்டன் , ப்ரெஸ்பிடீரியந் மருத்துவமனை கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் , போஸ்டன் அறிவியல் , ம்ட் பல்கலைக்கழகம் ஆஃப் மிச்சிகன் இருதய மையம் ,